Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Strategy
Growth at ‘Any Cost’ Is Over: CFO Panel
At the CFO Leadership Conference, speakers noted inflation, tight labor markets, and higher interest rates change the way CFOs pursue growth.
By
Vincent Ryan
| May 19, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Takeover
Technology
Microsoft Makes $26B Connection With LinkedIn
Microsoft's largest-ever acquisition "brings together the world’s leading professional cloud with the world’s leading professional network," its CEO says.
By
Matthew Heller
| June 13, 2016
Read More
Strategy
Tribune Aims to Kill Gannett Bid
The publishing company has also sold a $70 million stake to a billionaire investor as it continues to put obstacles in the way of a hostile takeover.
By
Katie Kuehner-Hebert
| May 24, 2016
Read More
Tax
CF Scraps $8B Deal Due to New Inversion Rules
The fertilizer company says the U.S. crackdown on tax inversions had reduced the benefits of its proposed merger with OCI NV.
By
Matthew Heller
| May 23, 2016
Read More
Strategy
Bayer Discloses $62B Offer for Monsanto
The deal would create the world's largest agricultural supplier but Bayer shareholders fear it will be detrimental to its pharmaceutical business
By
Katie Kuehner-Hebert
| May 23, 2016
Read More
Technology
Square Stock up 8% on News of Visa’s Stake
The disclosure of the size of Visa's 2011 investment fuels speculation about its plans with the mobile payments startup.
By
Matthew Heller
| February 16, 2016
Read More
M&A
Endurance Buys Constant Contact for $1.1B
Online services provider Endurance International is seeking to bolster its offerings to small businesses but its stock slid 23% on news of the deal.
By
Katie Kuehner-Hebert
| November 2, 2015
Read More
Strategy
Shire to Buy Rival Drug Maker Dyax for $5.9B
The deal gives the acquisitive Irish company access to an experimental drug that competes with its own treatment for a rare disease.
By
Matthew Heller
| November 2, 2015
Read More
Strategy
KeyCorp Buys First Niagara for $4.1 Billion
The largest deal this year between two U.S. regional banks is another indication of a pickup in M&A activity in the banking industry.
By
Katie Kuehner-Hebert
| October 30, 2015
Read More
Strategy
Snyder’s-Lance Snaps Up Diamond Foods for $1.2B
The acquisition of Diamond Foods adds Kettle potato chips to Snyder's-Lance's brands and could help the company expand in Europe.
By
Matthew Heller
| October 28, 2015
Read More
Strategy
Anheuser-Busch InBev Mulling Bid for SABMiller
A merger of the two companies would create a brewing behemoth but could face antitrust hurdles in the U.S.
By
Katie Kuehner-Hebert
| September 16, 2015
Read More
Strategy
Zoetis Gives Back Post-Takeover Report Gains
Shares in the animal-health giant take a rollercoaster ride after a report of a possible acquisition by Valeant Pharmaceuticals.
By
Matthew Heller
| June 26, 2015
Read More
M&A
Hoax $8B Tender Offer Sparks Avon Stock Surge
Avon quickly indicated the offer from a purported U.K. private equity firm was bogus.
By
Katie Kuehner-Hebert
| May 15, 2015
Read More
Strategy
Getting Defensive
A CFO's key role at CSC helped thwart a hostile bid.
By
Linda Corman
| May 1, 1998
Read More
Previous